Most adults with pulmonary arterial hypertension (PAH) experience no worsening and may even see a reduction in the severity…
Articles by Margarida Maia, PhD
The matrix around the heart’s cells does not shrink and may continue to undergo changes after pulmonary endarterectomy, or PEA,…
The gene coding for insulin-like growth factor 1 (IGF1) may be involved in both pulmonary hypertension (PH) and…
Engaging in inspiratory muscle training for eight weeks may help people with pulmonary hypertension (PH) strengthen their respiratory (breathing)…
The risk of mortality is nine times greater for people who have signs of pulmonary hypertension (PH) on an…
Roughly one in four people with idiopathic (of unknown cause) pulmonary arterial hypertension (PAH) also have diabetes, a disease…
Switching to Orenitram, an oral formulation of treprostinil, appears safe and may benefit some patients with pulmonary arterial hypertension…
People with precapillary pulmonary hypertension (PH) and a poorly working right ventricle may benefit from ranolazine, which is used…
Developing chronic thromboembolic pulmonary hypertension (CTEPH) within two years after a venous thromboembolism (VTE), which occurs when a blood…
MRE-269, an active metabolite of Uptravi (selexipag), is more effective at stopping the growth of lung cells from people with…
Members from two families with diagnosed or suspected pulmonary arterial hypertension (PAH) each carried two copies of mutations that…
More than half of people with pulmonary hypertension (PH) may experience symptoms during sexual activity, such as difficulty…